XML 62 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Compensation Related Costs, Share Based Payments (Tables)
12 Months Ended
Dec. 27, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Awards
The following awards were outstanding during 2020:
Benefit PlanAward TypeGrant DateGrant Date Fair Value per AwardVesting ConditionVesting DateIntended Settlement MethodMilestone Date Fair Value per AwardAwards GrantedPerformance
Target
Achievement
Award Adjustment
Awards Forfeited to Date
2009 LTIPRSU3/1/2018$24.93Service(a)StockNA163,764 — (51,473)
2009 LTIPRSU3/1/2018$24.93Performance/Service(b)StockNA217,253 (53,381)(78,449)
2009 LTIPRSU3/1/2018$24.93Performance/Service(c)Cash$19.3566,272 (17,863)(15,235)
2009 LTIPRSU5/10/2018$21.54Service(d)StockNA8,358 — — 
2009 LTIPRSU1/7/2019$16.47Performance/Service(e)StockNA414,620 39,620 (137,413)
2009 LTIPRSU1/7/2019$16.47Performance/Service(f)Cash$19.35109,654 13,705 — 
2009 LTIPRSU4/30/2019$26.91Service7/1/2020Cash$15.12200,000 — — 
2009 LTIPRSU4/30/2019$26.91Performance/Service(g)StockNA470,000 — (470,000)
2009 LTIPRSU5/24/2019$27.86Service(d)StockNA11,170 — — 
2019 LTIPRSU1/8/2020$30.94Performance/Service(h)StockNA195,140 — (33,729)
2019 LTIPRSU1/8/2020$30.94Performance/Service(i)Cash$19.35121,310 — — 
2019 LTIPRSU4/29/2020$22.01Service(d)StockNA13,630 — — 
(a)    The restricted stock units vest in ratable tranches on December 31, 2018, December 31, 2019 and December 31, 2020. Expected compensation cost related to these units totals $2.8 million based on a closing stock price for the Company’s common stock of $24.93 per share on March 1, 2018. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(b)    The restricted stock units vest in ratable tranches on December 31, 2019, December 31, 2020 and December 31, 2021. Expected compensation cost related to these units totals $2.1 million based on a closing stock price for the Company’s common stock of $24.93 per share on March 1, 2018. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(c)    The restricted stock units vest in ratable tranches on December 31, 2019, December 31, 2020 and December 31, 2021. Expected compensation cost related to these units totals $0.6 million based on a closing stock price for the Company's common stock of $19.35 per share on December 27, 2020. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(d)    These restricted stock units were granted to the non-employees who currently serve on the Company's Board of Directors. Each participating director's units will vest upon his departure from the Company's Board of Directors. Compensation cost was recognized in profit/loss upon the grant date.
(e)    The restricted stock units vest in ratable tranches on December 31, 2020, December 31, 2021 and December 31, 2022. Expected compensation cost related to these units totals $5.2 million based on a closing stock price for the Company's common stock of $16.47 per share on January 7, 2019. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(f)    The restricted stock units vest in ratable tranches on December 31, 2020, December 31, 2021 and December 31, 2022. Expected compensation cost related to these units totals $2.1 million based on a closing stock price for the Company's common stock of $19.35 per share on December 27, 2020. Compensation cost will be amortized to profit/loss upon satisfaction of the performance conditions over the remaining vesting period.
(g)    The restricted stock units were cancelled in their entirety by the Company's Board of Directors on December 8, 2020.
(h)    If performance conditions related to the Company's 2020 operating results are satisfied, the restricted stock units vest in ratable tranches on December 31, 2021, December 31, 2022 and December 31, 2023. Expected compensation cost related to these units totals $5.0 million based on a closing stock price for the Company's common stock of $30.94 per share on January 8, 2020. Compensation cost will be amortized to profit/loss upon satisfaction of the performance conditions over the remaining vesting period.
(i)    If performance conditions related to the Company's 2020 operating results are satisfied, the restricted stock units vest in ratable tranches on December 31, 2021, December 31, 2022 and December 31, 2023. Expected compensation cost related to these units totals $3.8 million based on a closing stock price for the Company's common stock of $30.94 per share on December 27, 2020. Compensation cost will be amortized to profit/loss upon satisfaction of the performance conditions over the remaining vesting period.
Schedule of Compensation Cost and Income Tax Benefit
Compensation costs and the income tax benefit recognized for our stock-based compensation arrangements are included below:
202020192018
(In thousands)
Equity-based awards compensation cost:
Cost of sales$838 $461 $389 
Selling, general and administrative expense1,938 9,671 12,764 
Total cost2,776 10,132 13,153 
Income tax benefit676 2,466 3,202 
Net cost$2,100 $7,666 $9,951 
Liability-based awards compensation cost:
Selling, general and administrative expense$1,081 $671 $— 
Income tax benefit263 163 — 
Net cost$818 $508 $— 
Schedule of RSU Activity
The Company’s RSU activity is included below:
202020192018
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
(In thousands, except weighted average fair values)
Equity-based RSUs:
Outstanding at beginning of year926 $24.04 1,069 $22.97 389 $18.39 
Transferred to liability-based awards(200)26.91 (36)24.67 — — 
Granted249 28.14 843 22.01 1,114 23.05 
Vested(66)24.93 (723)22.08 — — 
Forfeited(325)25.95 (227)21.51 (434)19.06 
Outstanding at end of year584 $22.12 926 $24.04 1,069$22.97 
202020192018
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
(In thousands, except weighted average fair values)
Liability-based RSUs:
Outstanding at beginning of year143 $32.97 — $— — $— 
Transferred from equity-based awards200 26.91 36 14.77 — — 
Granted135 29.47 110 16.47 — — 
Vested(211)16.04 (3)26.86 — — 
Forfeited— — — — — — 
Outstanding at end of year267 $19.35 143 $32.97 — $— 
(a)    The milestone date fair value is either the closing price of the Company’s common stock on the grant date for equity-based awards or the closing price of a share of the Company's common stock on the respective milestone date for cash-based liability-based awards (i.e., grant date, vesting date, forfeiture date or financial reporting date).